Maravai LifeSciences (MRVI) News and press releases

5 Value Stocks In The Healthcare Sector

30 Jan 23

News

Goldman Sachs Maintains Buy on Maravai LifeSciences, Lowers Price Target to $16

17 Jan 23

News, Price Target, Analyst Ratings

Goldman Sachs analyst Matthew Sykes maintains Maravai LifeSciences (NASDAQ:MRVI) with a Buy and lowers the price target from $18 to $16.

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

5 Jan 23

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

UBS Downgrades Maravai LifeSciences to Neutral, Lowers Price Target to $16

5 Jan 23

News, Downgrades, Price Target, Analyst Ratings

UBS analyst Dan Brennan downgrades Maravai LifeSciences (NASDAQ:MRVI) from Buy to Neutral and lowers the price target from $20 to $16.

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022

14 Dec 22

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

Deutsche Bank Initiates Coverage On Maravai LifeSciences with Buy Rating, Announces Price Target of $25

14 Dec 22

News, Price Target, Initiation, Analyst Ratings

Deutsche Bank analyst Justin Bowers initiates coverage on Maravai LifeSciences (NASDAQ:MRVI) with a Buy rating and announces Price Target of $25.

Stocks That Hit 52-Week Lows On Thursday

8 Dec 22

Options

During Thursday's trading, 138 companies set new 52-week lows.

Where Maravai LifeSciences Stands With Analysts

7 Dec 22

Analyst Ratings

6 Analysts Have This to Say About Maravai LifeSciences

7 Dec 22

Analyst Ratings

RBC Capital Initiates Coverage On Maravai LifeSciences with Outperform Rating, Announces Price Target of $22

7 Dec 22

News, Price Target, Initiation, Analyst Ratings

RBC Capital analyst Conor McNamara initiates coverage on Maravai LifeSciences (NASDAQ:MRVI) with a Outperform rating and announces Price Target of $22.

Stocks That Hit 52-Week Lows On Tuesday

6 Dec 22

Options

Tuesday's session saw 167 companies set new 52-week lows.

Maravai LifeSciences Announces Updated CEO Leadership Transition Plans

1 Dec 22

News, Management

Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced plans for William "Trey" Martin, III to serve as President

Maravai LifeSciences Announces Updated CEO Leadership Transition Plans

1 Dec 22

News, Management, Press Releases

Maravai announces plans for William "Trey" Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai's CEO in July 2023 Carl Hull to

Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America

16 Nov 22

Press Releases

SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it ranked 270 on the